Effect of SGLT2 inhibitors versus DPP4 inhibitors on major adverse kidney events in diabetic people with varied kidney function decline
SGLT2i therapy was associated with better kidney outcomes and slower eGFR decline than DPP4i regardless of prior rapid eGFR decline.
Authors
- Yu‐Wen Cheng (ORCID: https://orcid.org/0000-0003-3714-0464)
- Shao-Wei Chen (ORCID: https://orcid.org/0000-0003-1674-1295)
- Tze-Fan Chao
- Yi-Wei Kao
- Yi-Hsin Chan
Institutions
- Fu Jen Catholic University (TW)
- Memorial Hospital of South Bend (US)
- National Yang Ming Chiao Tung University (TW)
- Chang Gung University (TW)
- Ming Chuan University (TW)
- Taipei Veterans General Hospital (TW)
- Chang Gung Memorial Hospital (TW)
- Linkou Chang Gung Memorial Hospital (TW)
- Changchun University of Chinese Medicine (CN)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2026-01-15
- DOI
- https://doi.org/10.3389/fendo.2025.1647342
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Chang Gung Medical Foundation
- Ministry of Science and Technology, Taiwan
- Chang Gung Memorial Hospital, Linkou